The short bowel syndrome market is poised for significant change, with next-generation GLP-2 analogues such as apraglutide (Ironwood Pharmaceuticals), glepaglutide…
Ad-supported streaming gross revenue up year-over-year when excluding political and advocacy. Early programmatic scale and international expansion drove nearly 40%…
LAVAL, QC, Nov. 24, 2025 /PRNewswire/ – Alimentation Couche-Tard Inc. (“Couche-Tard” or the “Corporation”) (TSX: ATD) announces its results for its second quarter ended…